Global LDL Test Market – Industry Trends and Forecast to 2026
Short Description
By Component (Kits & Reagents, Devices, Services), Disease (Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Others), Distribution Channel (Direct Tenders, Retail), End User (Hospitals, Clinics, Ambulatory Care, Research Laboratory), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Market Definition
Low density lipoprotein (LDL) is known as bad cholesterol because it contains extra fat in arteries. These conditions narrow the arteries and raise the risk of heart attack, stroke and peripheral artery disease. So for the determination of LDL, various kits, reagent and devices are used. For instance N-geneous LDL cholesterol calibrator which is used as LDL test in determination of low density lipoprotein for measuring risk of heart diseases. It is basically for in-vitro diagnostic use. The test LDL cholesterol act as a key factor for determining the pathogenesis of atherosclerosis and coronary heart disease. By the use of this test it is easy to find out the associated risk of heart diseases. Hence, as per the test study result the increase in LDL cholesterol can occur with an associated increase risk of CAD (cardiovascular diseases).
Market Segmentation
Global LDL test market is segmented into four notable segments such as components, disease, end user and distribution channel.
• On the basis of component, the market is segmented into devices, kits & reagents and services. Devices are further segmented into spectrophotometer, syringes & needles, others.
• On the basis of disease, the market is segmented into atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease, others.
• On the basis of distribution channel, the market is segmented into direct tenders and retail.
• On the basis of end user, the market is segmented into hospitals, clinics, research laboratory, and ambulatory care.
Market Players
The key market players are listed below:
• Quest Diagnostics
• Sekisui Diagnostics
• Express Biotech International
• Randox Laboratories Ltd
• Reckon diagnostics
• Diasys Diagnostic Systems GmbH
• F. Hoffmann-La Roche Ltd
• Abbott
• Eurolyser Diagnostica GmbH
• Sigma-Aldrich
• Diazyme Laboratories, Inc.
• Laboratory Corporation of America
The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Global Ldl Test Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Global Ldl Test Market: Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Research Methodology
- 2.6 Dbmr Market Position Grid
- 2.7 Dbmr Market Challenge Matrix
- 2.8 Dbmr Vendor Share Analysis
- 2.9 Multivariate Modeling
- 2.10 Products Lifeline Curve
- 2.11 Key Primary Insights
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Market Overview
- 3.1 Drivers
- 3.1.1 Rising Awareness Among Patient
- 3.1.2 Increasing Prevalence Of Cardiovascular Diseases And Obesity
- 3.1.3 Increasing Number Of Geriatric People
- 3.1.4 Government Initiatives To Improve Quality Of Testing
- 3.2 Restraints
- 3.2.1 Risks Associated With Tests Like Bleeding And Infection
- 3.2.2 Emergence Of Non-invasive Cholesterol Testing Methods
- 3.3 Opportunities
- 3.3.1 High Growth Possibility In Ldl Test In Developing Countries
- 3.3.2 Patient-initiated Testing
- 3.4 Challenges
- 3.4.1 Patient Data Security
- 3.4.2 Evolving Regulatory Policies
- 4 Executive Summary
- 5 Premium Insights
- 6 Global Ldl Test Market, By Components
- 6.1 Overview
- 6.2 Kits & Reagents
- 6.3 Devices
- 6.3.1 Spectrophotometer
- 6.3.2 Syringes And Needles
- 6.3.3 Others
- 6.4 Services
- 7 Global Ldl Testing Market, By Disease
- 7.1 Overview
- 7.2 Diabetes
- 7.3 Stroke
- 7.4 Atherosclerosis
- 7.5 Obesity
- 7.6 Dyslipidemia
- 7.7 Carotid Artery Disease
- 7.8 Peripheral Arterial Disease
- 7.9 Angina
- 7.10 Others
- 8 Global Ldl Test Market, By Distribution Channel
- 8.1 Overview
- 8.2 Direct Tenders
- 8.3 Retail
- 9 Global Ldl Test Market, By End User
- 9.1 Overview
- 9.2 Hospitals
- 9.3 Clinics
- 9.4 Ambulatory Care
- 9.5 Research Laboratory
- 10 Global Ldl Test Market, By Geography
- 10.1 Overview
- 10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
- 10.2.3 Mexico
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 U.K
- 10.3.3 France
- 10.3.4 Italy
- 10.3.5 Spain
- 10.3.6 Switzerland
- 10.3.7 Netherlands
- 10.3.8 Russia
- 10.3.9 Belgium
- 10.3.10 Turkey
- 10.3.11 Rest Of Europe
- 10.4 Asia-pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Singapore
- 10.4.7 Malaysia
- 10.4.8 Indonesia
- 10.4.9 Thailand
- 10.4.10 Philippines
- 10.4.11 Rest Of Asia-pacific
- 10.5 South America
- 10.5.1 Brazil
- 10.5.2 Rest Of South America
- 10.6 Middle East And Africa
- 10.6.1 South Africa
- 10.6.2 Rest Of Middle East And Africa
- 11 Global Ldl Test Market, Company Landscape
- 11.1 Company Share Analysis: Global
- 11.2 Company Share Analysis: North America
- 11.3 Company Share Analysis: Europe
- 11.4 Company Share Analysis: Asia-pacific
- 12 Swot Analysis
- 12.1 Strength
- 12.2 Weakness
- 12.3 Opportunity
- 12.4 Threat
- 12.5 Data Bridge Market Research Analysis
- 13 Company Profile
- 13.1 F. Hoffmann-la Roche Ltd
- 13.1.1 Company Snapshot
- 13.1.2 Revenue Analysis
- 13.1.3 Company Share Analysis
- 13.1.4 Geographical Presence
- 13.1.5 Product Portfolio
- 13.1.6 Recent Developments
- 13.2 Merck Kgaa
- 13.2.1 Company Snapshot
- 13.2.2 Revenue Analysis
- 13.2.3 Company Share Analysis
- 13.2.4 Geographical Presence
- 13.2.5 Product Portfolio
- 13.2.6 Recent Development
- 13.3 Abbott
- 13.3.1 Company Snapshot
- 13.3.2 Revenue Analysis
- 13.3.3 Company Share Analysis
- 13.3.4 Geographical Presence
- 13.3.5 Product Portfolio
- 13.3.6 Recent Developments
- 13.4 Sekisui Diagnostics
- 13.4.1 Company Snapshot
- 13.4.2 Company Share Analysis
- 13.4.3 Geographical Presence
- 13.4.4 Product Portfolio
- 13.4.5 Recent Development
- 13.5 Atlas Medical U.K
- 13.5.1 Company Snapshot
- 13.5.2 Geographical Presence
- 13.5.3 Product Portfolio
- 13.5.4 Recent Developments
- 13.6 Cell Biolabs, Inc
- 13.6.1 Company Snapshot
- 13.6.2 Geographical Presence
- 13.6.3 Product Portfolio
- 13.6.4 Recent Developments
- 13.7 Diasys Diagnostic Systems Gmbh
- 13.7.1 Company Snapshot
- 13.7.2 Geographical Presence
- 13.7.3 Product Portfolio
- 13.7.4 Recent Development
- 13.8 Diazyme Laboratories, Inc
- 13.8.1 Company Snapshot
- 13.8.2 Geographical Presence
- 13.8.3 Product Portfolio
- 13.8.4 Recent Developments
- 13.9 Eurofins Scientific
- 13.9.1 Company Snapshot
- 13.9.2 Revenue Analysis
- 13.9.3 Geographical Presence
- 13.9.4 Product Portfolio
- 13.9.5 Recent Development
- 13.10 Eurolyser Diagnostica Gmbh
- 13.10.1 Company Snapshot
- 13.10.2 Geographical Presence
- 13.10.3 Product Portfolio
- 13.10.1 Recent Developments
- 13.11 Express Biotech International
- 13.11.1 Company Snapshot
- 13.11.2 Geographical Presence
- 13.11.3 Product Portfolio
- 13.11.4 Recent Developments
- 13.12 Home Access Health
- 13.12.1 Company Snapshot
- 13.12.2 Product Portfolio
- 13.12.3 Recent Developments
- 13.13 Laboratory Corporation Of America
- 13.13.1 Company Snapshot
- 13.13.2 Revenue Analysis
- 13.13.3 Geographical Presence
- 13.13.4 Product Portfolio
- 13.13.5 Recent Developments
- 13.14 Quest Diagnostics
- 13.14.1 Company Snapshot
- 13.14.2 Revenue Analysis
- 13.14.3 Geographical Presence
- 13.14.4 Product Portfolio
- 13.14.5 Recent Development
- 13.15 Randox Laboratories Ltd
- 13.15.1 Company Snapshot
- 13.15.2 Geographical Presence
- 13.15.3 Product Portfolio
- 13.15.4 Recent Development
- 13.16 Reckondiagnostics
- 13.16.1 Company Snapshot
- 13.16.2 Product Portfolio
- 13.16.3 Recent Developments
- 13.17 Thermo Fisher Scientific Inc
- 13.17.1 Company Snapshot
- 13.17.2 Revenue Analysis
- 13.17.3 Geographical Presence
- 13.17.4 Product Portfolio
- 13.17.5 Recent Developments
- 14 Conclusion
- 15 Questionnaire
- 16 Related Reports
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook